von Tobias Borgers | Jan. 10, 2024 | Boehringer
INGELHEIM, Germany and SOUTH SAN FRANCISCO, Calif., Jan. 4, 2024 /PRNewswire/ — Boehringer Ingelheim and 3T Biosciences („3T“) today announced they have entered into a new strategic collaboration and licensing agreement focused on discovering and...
von Ulrich Kramer | Dez. 21, 2023 | Markt
Schott Pharma verdient im Geschäftsjahr mehr dank lukrativer Produkte MAINZ (dpa-AFX) – Der SDax-Neuling Schott Pharma hat im vergangenen Geschäftsjahr trotz des Lagerabbaus bei Kunden mehr verdient. Die Mainzer profitierten eigenen Angaben vom Dienstag zufolge...
von Tobias Borgers | Dez. 21, 2023 | Boehringer
This webcast features: Athelney Woolnough, Director Business Development/Key Account Management BioXcellence, Franz Schuster, Strategy Implementation Manager Biopharma Austria, Cécile Brocard, Director of Downstream Development, Process Science RCV, Boehringer...
von Tobias Borgers | Dez. 21, 2023 | Boehringer
RealmFive, a leader in data connectivity and digital solutions based in Lincoln, Neb., has teamed up with Boehringer Ingelheim Animal Health, to commercialize next-generation technology-based solutions for advancing remote connectivity and herd health across the swine...
von Tobias Borgers | Dez. 14, 2023 | Boehringer
Oxford BioTherapeuticsBI 764532 was discovered using OBT’s proprietary OGAP® platform, the world’s largest, cancer specific, membrane protein library used to identify novel, high specific antigens for cancer targetsOxford, UK, San Jose, Calif., 24th October 2023...
